Skip to main content

Table 3 Univariate and multivariate analysis for disease-specific survival

From: Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy

 

Disease-specific survival

 

Univariate analysis

Multivariate analysis

Characteristics

P

HR (95 % CI)

P

Age (<70 years vs. ≥70 years)

0.37

  

Sex (male vs. female)

0.034

0.15 (0.03-0.79)

0.025

Pathological T stage (T1 vs. T2)

0.18

  

Histological grade (low vs. high)

0.38

  

Concurrent CIS (Yes vs. No)

0.18

  

Lymphovascular invasion (Yes vs. No)

0.35

  

DYRK2 expression (positive vs. negative)

0.017

11.5 (1.29-102)

0.029